185 related articles for article (PubMed ID: 20573279)
1. Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice.
El Khoury D; Destouches D; Lengagne R; Krust B; Hamma-Kourbali Y; Garcette M; Niro S; Kato M; Briand JP; Courty J; Hovanessian AG; Prévost-Blondel A
BMC Cancer; 2010 Jun; 10():325. PubMed ID: 20573279
[TBL] [Abstract][Full Text] [Related]
2. Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type.
Krust B; El Khoury D; Nondier I; Soundaramourty C; Hovanessian AG
BMC Cancer; 2011 Aug; 11():333. PubMed ID: 21812966
[TBL] [Abstract][Full Text] [Related]
3. Suppression of tumorigenicity of rhabdoid tumor derived G401 cells by the multivalent HB-19 pseudopeptide that targets surface nucleolin.
Krust B; El Khoury D; Soundaramourty C; Nondier I; Hovanessian AG
Biochimie; 2011 Mar; 93(3):426-33. PubMed ID: 21040752
[TBL] [Abstract][Full Text] [Related]
4. Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin.
Destouches D; El Khoury D; Hamma-Kourbali Y; Krust B; Albanese P; Katsoris P; Guichard G; Briand JP; Courty J; Hovanessian AG
PLoS One; 2008 Jun; 3(6):e2518. PubMed ID: 18560571
[TBL] [Abstract][Full Text] [Related]
5. The new face of nucleolin in human melanoma.
Hoja-Łukowicz D; Przybyło M; Pocheć E; Drabik A; Silberring J; Kremser M; Schadendorf D; Laidler P; Lityńska A
Cancer Immunol Immunother; 2009 Sep; 58(9):1471-80. PubMed ID: 19363676
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of hyperpigmented skin on UV-mediated cutaneous cancer development.
Kato M; Ohgami N; Kawamoto Y; Tsuzuki T; Hossain K; Yanagishita T; Ohshima Y; Tsuboi H; Yamanoshita O; Matsumoto Y; Takahashi M; Nakashima I
J Invest Dermatol; 2007 May; 127(5):1244-9. PubMed ID: 17159911
[TBL] [Abstract][Full Text] [Related]
7. The anti-HIV pentameric pseudopeptide HB-19 binds the C-terminal end of nucleolin and prevents anchorage of virus particles in the plasma membrane of target cells.
Nisole S; Said EA; Mische C; Prevost MC; Krust B; Bouvet P; Bianco A; Briand JP; Hovanessian AG
J Biol Chem; 2002 Jun; 277(23):20877-86. PubMed ID: 11919179
[TBL] [Abstract][Full Text] [Related]
8. The histone code reader SPIN1 controls RET signaling in liposarcoma.
Franz H; Greschik H; Willmann D; Ozretić L; Jilg CA; Wardelmann E; Jung M; Buettner R; Schüle R
Oncotarget; 2015 Mar; 6(7):4773-89. PubMed ID: 25749382
[TBL] [Abstract][Full Text] [Related]
9. Early development of PAT-SM6 for the treatment of melanoma.
Hensel F; Eckstein M; Rosenwald A; Brändlein S
Melanoma Res; 2013 Aug; 23(4):264-75. PubMed ID: 23728394
[TBL] [Abstract][Full Text] [Related]
10. Cell-surface nucleolin acts as a central mediator for carcinogenic, anti-carcinogenic, and disease-related ligands.
Fujiki H; Watanabe T; Suganuma M
J Cancer Res Clin Oncol; 2014 May; 140(5):689-99. PubMed ID: 24469254
[TBL] [Abstract][Full Text] [Related]
11. p54nrb is a new regulator of progression of malignant melanoma.
Schiffner S; Zimara N; Schmid R; Bosserhoff AK
Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354
[TBL] [Abstract][Full Text] [Related]
12. The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis.
Izraely S; Sagi-Assif O; Klein A; Meshel T; Tsarfaty G; Pasmanik-Chor M; Nahmias C; Couraud PO; Ateh E; Bryant JL; Hoon DS; Witz IP
Int J Cancer; 2012 Sep; 131(5):1071-82. PubMed ID: 22025079
[TBL] [Abstract][Full Text] [Related]
13. A novel hairless mouse model for malignant melanoma.
Thang ND; Yajima I; Nakagawa K; Tsuzuki T; Kumasaka MY; Ohgami N; Ly TB; Iwamoto T; Watanabe D; Kato M
J Dermatol Sci; 2012 Mar; 65(3):207-12. PubMed ID: 22169325
[TBL] [Abstract][Full Text] [Related]
14. Distinct role for CD8 T cells toward cutaneous tumors and visceral metastases.
Lengagne R; Graff-Dubois S; Garcette M; Renia L; Kato M; Guillet JG; Engelhard VH; Avril MF; Abastado JP; Prévost-Blondel A
J Immunol; 2008 Jan; 180(1):130-7. PubMed ID: 18097012
[TBL] [Abstract][Full Text] [Related]
15. The critical role of mast cell-derived hypoxia-inducible factor-1α in human and mice melanoma growth.
Jeong HJ; Oh HA; Nam SY; Han NR; Kim YS; Kim JH; Lee SJ; Kim MH; Moon PD; Kim HM; Oh HA
Int J Cancer; 2013 Jun; 132(11):2492-501. PubMed ID: 23161568
[TBL] [Abstract][Full Text] [Related]
16. The anti-HIV pseudopeptide HB-19 forms a complex with the cell-surface-expressed nucleolin independent of heparan sulfate proteoglycans.
Nisole S; Krust B; Callebaut C; Guichard G; Muller S; Briand JP; Hovanessian AG
J Biol Chem; 1999 Sep; 274(39):27875-84. PubMed ID: 10488134
[TBL] [Abstract][Full Text] [Related]
17. A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism.
Reyes-Reyes EM; Teng Y; Bates PJ
Cancer Res; 2010 Nov; 70(21):8617-29. PubMed ID: 20861190
[TBL] [Abstract][Full Text] [Related]
18. Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs.
Kimpfler S; Sevko A; Ring S; Falk C; Osen W; Frank K; Kato M; Mahnke K; Schadendorf D; Umansky V
J Immunol; 2009 Nov; 183(10):6330-7. PubMed ID: 19841169
[TBL] [Abstract][Full Text] [Related]
19. Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex.
Wise JF; Berkova Z; Mathur R; Zhu H; Braun FK; Tao RH; Sabichi AL; Ao X; Maeng H; Samaniego F
Blood; 2013 Jun; 121(23):4729-39. PubMed ID: 23599269
[TBL] [Abstract][Full Text] [Related]
20. Semaphorin 3A suppresses tumor growth and metastasis in mice melanoma model.
Chakraborty G; Kumar S; Mishra R; Patil TV; Kundu GC
PLoS One; 2012; 7(3):e33633. PubMed ID: 22448259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
